Benefits
Restorative sleep improvement
In the manufacturer's own 4-week trial (reported by PLT Health Solutions, released as a conference abstract and not among the peer-reviewed references cited on this page), the Serezin group reported a 64% greater improvement in restorative sleep quality than placebo. This figure has not been independently published, peer-reviewed, or replicated. Unlike melatonin or sedatives, Serezin is proposed to work by easing the discomfort that disrupts sleep rather than by inducing sedation; this is the rationale behind the formula rather than a separately demonstrated mechanism.
Nighttime and daytime pain reduction
In the manufacturer's 4-week trial (not among the peer-reviewed references cited on this page), discomfort scores improved by Day 7, and by Day 28 the Serezin group reported a 2.6x greater reduction in nighttime discomfort and a 75% greater reduction in daytime discomfort than placebo. The cited peer-reviewed studies below support the individual components for occasional aches and joint comfort: Boswellia extract improved knee pain and function in adults over 40 (Pérez-Piñero 2023) and in knee osteoarthritis (Sengupta 2008), and ginger reduced exercise-induced muscle pain (Black 2010). None of those trials measured sleep.
Sleep onset and quality
In the manufacturer's 4-week trial, subjects reported 85% greater improvement in ease of falling asleep and 93% greater improvement in sleep quality versus placebo at Day 14 on the Leeds Sleep Evaluation Questionnaire, with similar results in men and women; a women-only analysis was presented as an abstract in the SLEEP 2025 supplement. These are company-reported, self-rated questionnaire outcomes from a conference abstract rather than a peer-reviewed publication, and they are not among the references cited on this page.
Mood and morning alertness
In the manufacturer's 4-week trial, Serezin subjects reported a 2.2x improvement in overall mood scores along with easier waking and greater morning alertness. These are self-reported secondary outcomes from a company-run study that is not among the peer-reviewed references cited on this page, and they have not been independently confirmed.
Mechanism of action
Boswellic acid anti-inflammatory activity
Boswellia serrata extract inhibits 5-lipoxygenase (5-LOX), the enzyme that produces pro-inflammatory leukotrienes responsible for joint and soft tissue inflammation. This targeted anti-inflammatory action reduces the chronic low-grade pain that disrupts sleep quality in aging adults.
Ginger COX inhibition and analgesic activity
Zingiber officinale constituents (gingerols, shogaols) inhibit cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin-mediated pain signaling. Combining 5-LOX inhibition (Boswellia) with COX inhibition (ginger) is proposed to cover more of the inflammatory pain pathway than either ingredient alone. This synergy is a mechanistic rationale drawn from the separate component studies; no published head-to-head human trial has compared the blend against its individual components.
Circadian rhythm preservation
The rationale is that easing discomfort, rather than forcing sedation, lets normal sleep patterns take their own course. No polysomnography or other objective sleep-architecture or circadian measurements have been published for Serezin — the reported sleep outcomes are self-rated questionnaire scores — so any effect on sleep stages remains a proposed rationale rather than a measured result.
Clinical trials
10-day randomized, double-blind, placebo-controlled study of the Boswellia component (LI51202F1) and exercise-induced muscle soreness. (Manufacturer-conducted; PLT Health Solutions.) Note: this is a COMPONENT study — it did not test the finished Serezin blend and did not measure any sleep outcome. No trial of the finished Serezin blend has been published in peer-reviewed, PubMed-indexed form.
50 recreationally active men (mean age 28 ± 4) randomized to 60 mg standardized B. serrata extract LI51202F1 (the same extract used in Serezin™, water-soluble, ≥76% AKBA) or placebo for 10 days (6 days before, day of, and 3 days after downhill running). DOMS induced by three 15-min downhill running episodes on a 10% declined treadmill. Conducted by PLT Health Solutions and Yalamanchi Hospital and Research Centre.
B. serrata significantly attenuated muscle and joint soreness (VAS) and accelerated recovery of leg-extension 1RM strength after eccentric exercise vs placebo. The full Serezin® product (Boswellia + ginger) was also tested in a separate 4-week, 60-person 50-70 yr trial in adults with sleep disturbance from aches/pains; the abstract appeared in sleep 2025 Supplement (doi 10.1093/sleep/zsaf090.0941, conference abstract — not individually PubMed-indexed). PLT-reported Serezin findings: 64% greater restorative sleep improvement at 4 weeks, 2.6× reduction in nighttime discomfort, 75% reduction in daytime discomfort, 2.2× mood improvement. The full Serezin paper has not yet been published in PubMed-indexed peer-reviewed form. This study supports the Boswellia component's effect on exercise-related soreness and recovery only. It does not test sleep, and it does not test the finished Boswellia-plus-ginger Serezin blend.